Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension-Reference-Cited by-同舟云学术

Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension

Published:1987 Issue:1 Volume:32 Page:77-80
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Frithz G.,Weiner L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00609961.pdf

Reference17 articles.

1. Berglund G, Wedel H, Wilhelmsen L (1978) Coronary heart disease after treatment of hypertension. Lancet 8074: 1147?1148

2. Bielmann P, Leduc G, Jéquier J-C, Davignon J, Cartwright K (1981) Changes in the lipoprotein composition after chronic administration of metoprolol and propranolol in hypertriglyceridemic-hypertensive subjects. Curr Ther Res 30: 956?967

3. Carlson LA, Böttiger LE (1981) Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease? Atherosclerosis 39: 287?291

4. Distler A, Keim HJ, Cordes U, Philipp T, Wolff HP (1978) Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension. Am J Med 64: 446?451

5. Dorow P, Tönnesmann U (1984) Dose-response relationship for the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis. Eur J Clin Pharmacol 27: 135?139

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined diosmin and bisoprolol attenuate cobalt chloride-induced cardiotoxicity and endothelial dysfunction through modulating miR-143-3P/MAPK/MCP-1, ERK5/CXCR4, Orai-1/STIM-1 signaling pathways;International Immunopharmacology;2024-10

2. Features of management of patients with cardiometabolic polymorbidity phenotype: focus on the efficacy and safety of bisoprolol;Meditsinskiy sovet = Medical Council;2023-10-20

3. Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples;Pharmacology;2017-09-21

4. Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study;BMJ Open;2012

5. Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features;Cardiovascular Therapy and Prevention;2011-06-20